Literature DB >> 21391917

Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.

Knut Fälker1, Linda Haglund, Peter Gunnarsson, Martina Nylander, Tomas L Lindahl, Magnus Grenegård.   

Abstract

PARs (protease-activated receptors) 1 and 4 belong to the family of G-protein-coupled receptors which induce both G(α12/13) and G(αq) signalling. By applying the specific PAR1- and PAR4-activating hexapeptides, SFLLRN and AYPGKF respectively, we found that aggregation of isolated human platelets mediated via PAR1, but not via PAR4, is abolished upon homologous receptor activation in a concentration- and time-dependent fashion. This effect was not due to receptor internalization, but to a decrease in Ca²⁺ mobilization, PKC (protein kinase C) signalling and α-granule secretion, as well as to a complete lack of dense granule secretion. Interestingly, subthreshold PAR4 activation rapidly abrogated PAR1 signalling desensitization by differentially reconstituting these affected signalling events and functional responses, which was sufficient to re-establish aggregation. The lack of ADP release and P2Y₁₂ receptor-induced G(αi) signalling accounted for the loss of the aggregation response, as mimicking G(αi/z) signalling with 2-MeS-ADP (2-methylthioadenosine-5'-O-diphosphate) or epinephrine (adrenaline) could substitute for intermediate PAR4 activation. Finally, we found that the re-sensitization of PAR1 signalling-induced aggregation via PAR4 relied on PKC-mediated release of both ADP from dense granules and fibrinogen from α-granules. The present study elucidates further differences in human platelet PAR signalling regulation and provides evidence for a cross-talk in which PAR4 signalling counteracts mechanisms involved in PAR1 signalling down-regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391917     DOI: 10.1042/BJ20101360

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4.

Authors:  María de la Fuente; Daniel N Noble; Sheetal Verma; Marvin T Nieman
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 2.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

3.  Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.

Authors:  Jennifer Yeung; Patrick L Apopa; Joanne Vesci; Victor Kenyon; Ganesha Rai; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney; Olivier Boutaud; Michael Holinstat
Journal:  Mol Pharmacol       Date:  2011-12-09       Impact factor: 4.436

4.  Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.

Authors:  Matthew T Duvernay; Kayla J Temple; Jae G Maeng; Anna L Blobaum; Shaun R Stauffer; Craig W Lindsley; Heidi E Hamm
Journal:  Mol Pharmacol       Date:  2016-10-26       Impact factor: 4.436

5.  The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition.

Authors:  M J Whitley; D M Henke; A Ghazi; M Nieman; M Stoller; L M Simon; E Chen; J Vesci; M Holinstat; S E McKenzie; C A Shaw; L C Edelstein; P F Bray
Journal:  J Thromb Haemost       Date:  2018-11-22       Impact factor: 5.824

6.  Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.

Authors:  Matthew Duvernay; Summer Young; David Gailani; Jonathan Schoenecker; Heidi E Hamm; Heidi Hamm
Journal:  Mol Pharmacol       Date:  2013-01-10       Impact factor: 4.436

Review 7.  Protease-activated receptor 4: from structure to function and back again.

Authors:  Shauna L French; Justin R Hamilton
Journal:  Br J Pharmacol       Date:  2016-03-10       Impact factor: 8.739

8.  Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.

Authors:  Chantal C Clark; Bernard N Jukema; Arjan D Barendrecht; Judith S Spanjaard; Nikita K N Jorritsma; Simone Smits; Steven de Maat; Cor W Seinen; Sandra Verhoef; Naomi M J Parr; Silvie A E Sebastian; Arnold C Koekman; Annet C W van Wesel; Harriet M R van Goor; Roy Spijkerman; Suzanne H Bongers; Erhard van der Vries; Stefan Nierkens; Marianne Boes; Leo Koenderman; Karin A H Kaasjager; Coen Maas
Journal:  Front Med (Lausanne)       Date:  2021-04-22

9.  Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model.

Authors:  Abhineet Uppal; Sean C Wightman; Sabha Ganai; Ralph R Weichselbaum; Gary An
Journal:  Theor Biol Med Model       Date:  2014-04-12       Impact factor: 2.432

10.  Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.

Authors:  Naadiya Carrim; Jane F Arthur; Justin R Hamilton; Elizabeth E Gardiner; Robert K Andrews; Niamh Moran; Michael C Berndt; Pat Metharom
Journal:  Redox Biol       Date:  2015-10-28       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.